HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV Transmission

• Yegor Voronin ,

  * E-mail: yvoronin@vaccineenterprise.org

  Affiliation Global HIV Vaccine Enterprise, New York, New York, United States of America

  ⨯
• Lynne M. Mofenson,

  Affiliation Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Coleen K. Cunningham,

  Affiliation Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Mary G. Fowler,

  Affiliation Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Pontiano Kaleebu,

  Affiliation Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda

  ⨯
• Elizabeth J. McFarland,

  Affiliation University of Colorado School of Medicine, Denver, Colorado, United States of America

  ⨯
• Jeffrey T. Safrit,

  Affiliation Elizabeth Glaser Pediatric AIDS Foundation, Los Angeles, California, United States of America

  ⨯
• Barney S. Graham,

  Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• William Snow

  Affiliation Global HIV Vaccine Enterprise, New York, New York, United States of America

  ⨯